Jacobson Pharma Corporation Limited

SEHK:2633 Voorraadrapport

Marktkapitalisatie: HK$1.6b

Jacobson Pharma Dividenden en inkoop

Dividend criteriumcontroles 3/6

Jacobson Pharma is een dividendbetalend bedrijf met een huidig rendement van 6.71% dat ruimschoots wordt gedekt door de winst.

Belangrijke informatie

6.7%

Dividendrendement

-1.9%

Terugkoop Rendement

Totaal aandeelhoudersrendement4.8%
Toekomstig dividendrendementn/a
Dividendgroei21.0%
Volgende betaaldatum dividendn/a
Ex-dividenddatumn/a
Dividend per aandeelHK$0.055
Uitbetalingsratio23%

Recente updates van dividend en inkoop

Jacobson Pharma's (HKG:2633) Dividend Is Being Reduced To HK$0.025

Nov 27
Jacobson Pharma's (HKG:2633) Dividend Is Being Reduced To HK$0.025

Recent updates

There's Reason For Concern Over Jacobson Pharma Corporation Limited's (HKG:2633) Massive 27% Price Jump

Nov 22
There's Reason For Concern Over Jacobson Pharma Corporation Limited's (HKG:2633) Massive 27% Price Jump

Increases to Jacobson Pharma Corporation Limited's (HKG:2633) CEO Compensation Might Cool off for now

Aug 21
Increases to Jacobson Pharma Corporation Limited's (HKG:2633) CEO Compensation Might Cool off for now

Jacobson Pharma's (HKG:2633) Profits May Not Reveal Underlying Issues

Dec 21
Jacobson Pharma's (HKG:2633) Profits May Not Reveal Underlying Issues

Jacobson Pharma's (HKG:2633) Dividend Is Being Reduced To HK$0.025

Nov 27
Jacobson Pharma's (HKG:2633) Dividend Is Being Reduced To HK$0.025

These 4 Measures Indicate That Jacobson Pharma (HKG:2633) Is Using Debt Reasonably Well

Jun 20
These 4 Measures Indicate That Jacobson Pharma (HKG:2633) Is Using Debt Reasonably Well

Jacobson Pharma's (HKG:2633) Upcoming Dividend Will Be Larger Than Last Year's

Nov 28
Jacobson Pharma's (HKG:2633) Upcoming Dividend Will Be Larger Than Last Year's

Jacobson Pharma (HKG:2633) Is Increasing Its Dividend To HK$0.0268

Sep 25
Jacobson Pharma (HKG:2633) Is Increasing Its Dividend To HK$0.0268

Should Shareholders Reconsider Jacobson Pharma Corporation Limited's (HKG:2633) CEO Compensation Package?

Sep 16
Should Shareholders Reconsider Jacobson Pharma Corporation Limited's (HKG:2633) CEO Compensation Package?

Jacobson Pharma's (HKG:2633) Shareholders Will Receive A Bigger Dividend Than Last Year

Jul 28
Jacobson Pharma's (HKG:2633) Shareholders Will Receive A Bigger Dividend Than Last Year

Jacobson Pharma's (HKG:2633) Upcoming Dividend Will Be Larger Than Last Year's

Jul 14
Jacobson Pharma's (HKG:2633) Upcoming Dividend Will Be Larger Than Last Year's

Does Jacobson Pharma (HKG:2633) Have A Healthy Balance Sheet?

Feb 09
Does Jacobson Pharma (HKG:2633) Have A Healthy Balance Sheet?

Jacobson Pharma (HKG:2633) Is Increasing Its Dividend To HK$0.012

Nov 29
Jacobson Pharma (HKG:2633) Is Increasing Its Dividend To HK$0.012

Jacobson Pharma (HKG:2633) Is Reducing Its Dividend To HK$0.015

Sep 24
Jacobson Pharma (HKG:2633) Is Reducing Its Dividend To HK$0.015

Here's Why It's Unlikely That Jacobson Pharma Corporation Limited's (HKG:2633) CEO Will See A Pay Rise This Year

Sep 16
Here's Why It's Unlikely That Jacobson Pharma Corporation Limited's (HKG:2633) CEO Will See A Pay Rise This Year

Kwing Tong Lam Is The Independent Non-Executive Director of Jacobson Pharma Corporation Limited (HKG:2633) And They Just Picked Up 28% More Shares

Feb 03
Kwing Tong Lam Is The Independent Non-Executive Director of Jacobson Pharma Corporation Limited (HKG:2633) And They Just Picked Up 28% More Shares

A Look At The Fair Value Of Jacobson Pharma Corporation Limited (HKG:2633)

Jan 24
A Look At The Fair Value Of Jacobson Pharma Corporation Limited (HKG:2633)

Here's Why Jacobson Pharma (HKG:2633) Has A Meaningful Debt Burden

Jan 11
Here's Why Jacobson Pharma (HKG:2633) Has A Meaningful Debt Burden

Does Jacobson Pharma's (HKG:2633) CEO Salary Compare Well With The Performance Of The Company?

Dec 27
Does Jacobson Pharma's (HKG:2633) CEO Salary Compare Well With The Performance Of The Company?

Is It Smart To Buy Jacobson Pharma Corporation Limited (HKG:2633) Before It Goes Ex-Dividend?

Dec 12
Is It Smart To Buy Jacobson Pharma Corporation Limited (HKG:2633) Before It Goes Ex-Dividend?

Reflecting on Jacobson Pharma's (HKG:2633) Share Price Returns Over The Last Three Years

Dec 03
Reflecting on Jacobson Pharma's (HKG:2633) Share Price Returns Over The Last Three Years

Stabiliteit en groei van betalingen

Dividenden ophalen

Stabiel dividend: 2633 betaalt al minder dan 10 jaar dividend en gedurende deze periode zijn de betalingen volatiel geweest.

Groeiend dividend: De dividendbetalingen van 2633 zijn gestegen, maar het bedrijf heeft pas 8 jaar dividend uitgekeerd.


Dividendrendement versus markt

Jacobson Pharma Dividendrendement versus markt
Hoe verhoudt 2633 dividendrendement zich tot de markt?
SegmentDividendrendement
Bedrijf (2633)6.7%
Markt onderkant 25% (HK)3.3%
Markt Top 25% (HK)8.1%
Gemiddelde industrie (Pharmaceuticals)3.8%
Analist prognose (2633) (tot 3 jaar)n/a

Opmerkelijk dividend: Het dividend van 2633 ( 6.71% ) is hoger dan dat van de onderste 25% van de dividendbetalers op de Hong Kong markt ( 3.32% ).

Hoog dividend: Het dividend 2633 ( 6.71% ) is laag vergeleken met de top 25% van dividendbetalers in de Hong Kong markt ( 8.06% ).


Winstuitkering aan aandeelhouders

Verdiendekking: Met zijn lage payout ratio ( 23.2% ) worden de dividendbetalingen van 2633 ruimschoots gedekt door de winst.


Contante uitbetaling aan aandeelhouders

Kasstroomdekking: Met zijn redelijk lage cash payout ratio ( 30.7% ) worden de dividendbetalingen van 2633 goed gedekt door de kasstromen.


Ontdek bedrijven met een sterk dividend